Prosecution Insights
Last updated: April 19, 2026

Avalyn Pharma Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
0
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18664718 AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF TRUONG, QUANGLONG N 1615 Non-Final OA May 15, 2024
18042375 NEBULIZER DEVICE OPTIMIZATION FOR IMPROVED AEROSOL PARAMETERS AND USES THEREOF STANIS, TIMOTHY A 3785 Non-Final OA Feb 21, 2023
18171930 NEBULIZER DEVICE OPTIMIZATION FOR IMPROVED AEROSOL PARAMETERS AND USES THEREOF STANIS, TIMOTHY A 3785 Non-Final OA Feb 21, 2023
17028595 INHALED IMATINIB FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) HAGHIGHATIAN, MINA 1616 Non-Final OA Sep 22, 2020

Managing Avalyn Pharma Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month